Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Xamoterol, a new selective beta-1-adrenoceptor partial agonist, in the treatment of postural hypotension

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Hepatotoxicity of amiodarone

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Is adrenergic betareceptor blockade contraindicated in patients with intermittent claudication?

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The prevalence of secondary hypertension in elderly hypertensive patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Localization of aldosterone-producing tumours in primary aldosteronism by adrenal and renal vein catheterization

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Three patients severely disabled from postural hypotension were treated with xamoterol, a selective beta-1-adrenoceptor antagonist with a high degree of partial agonist activity. Oral treatment (200 mg b.i.d.) was chosen on the basis of the effects of acute intravenous administration of xamoterol and pindolol, a non-selective beta-adrenoceptor antagonist with partial agonist activity. In these patients pindolol had a predominantly antagonist effect, whereas xamoterol had a predominantly agonist effect after intravenous administration. Oral treatment was carried out with placebo control in a single-blind fashion. The patients reported gradual improvement during the first days of treatment. After 1 month of oral treatment, heart rate had increased by 15 beats/min, systolic blood pressure from 131 to 170 mmHg, diastolic blood pressure from 77 to 91 mmHg and mean blood pressure by 22 mmHg (mean values, supine). During the placebo period (2 weeks) heart rate decreased to pretreatment levels and mean blood pressure was reduced by only 14 mmHg. The patients reported substantial improvement in their condition during active medication. Xamoterol seems to be a useful alternative in the treatment of postural hypotension.
Original languageEnglish
JournalActa Medica Scandinavica
Volume219
Issue number2
Pages (from-to)173-7
Number of pages5
ISSN0001-6101
Publication statusPublished - 1986

    Research areas

  • Adrenergic beta-Agonists, Aged, Clinical Trials as Topic, Female, Hemodynamics, Humans, Hypotension, Orthostatic, Male, Middle Aged, Pindolol, Propanolamines, Xamoterol

ID: 42203765